Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
RENIS
Barreras de género en la prevención cardiovascular , actitudes y conocimientos de profesionales de la salud y/o en usuarios/pacientes
OBSERVATIONAL
ID: IS000022
Reclutando
Fase 3
ClinicalTrials.gov
EASi-HF Reduced - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Chronic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) < 40%
INTERVENTIONAL
Inicio: 20 de may de 2025
ID: NCT06935370
Completado
Fase 3
ClinicalTrials.gov
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure With Reduced Ejection Fraction
INTERVENTIONAL
Inicio: 8 de feb de 2017
ID: NCT03036124
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Orforglipron on the Incidence of Major Adverse Cardiovascular Events in Participants With Established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
INTERVENTIONAL
Inicio: 1 de dic de 2025
ID: NCT07241390
Reclutando
ClinicalTrials.gov
Cardiometabolic Risk Factors Registry
OBSERVATIONAL
Inicio: 1 de jun de 2015
ID: NCT04040777
Completado
Fase 3
ClinicalTrials.gov
An 8-week Randomised, Double-blind Study to Compare the Fixed-dose Combination of Telmisartan 80 + Amlodipine 10mg Versus Amlodipine 10 mg Monotherapy as First Line Therapy in Type 2 Diabetes Patients With Hypertension.
INTERVENTIONAL
Inicio: 1 de feb de 2009
ID: NCT00877929
Completado
Fase 3
ClinicalTrials.gov
A Phase III, 18 Month, Multicenter, Randomized, Double-Blind, Active-Controlled Clinical Trial to Compare Rosiglitazone Versus Glipizide on the Progression of Atherosclerosis in Subjects With Type 2 Diabetes Mellitus and Cardiovascular Disease (APPROACH)
INTERVENTIONAL
Inicio: 1 de ene de 2005
ID: NCT00116831
Reclutando
ClinicalTrials.gov
A Registry of Spontaneous Coronary Artery Dissection
OBSERVATIONAL
Inicio: 30 de ene de 2021
ID: NCT06601270
Completado
Fase 4
ClinicalTrials.gov
A Randomised, Double-Blind Placebo Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron Deficient Patients Admitted for Acute Heart Failure (Affirm-AHF)
INTERVENTIONAL
Inicio: 3 de abr de 2017
ID: NCT02937454
Completado
Fase 4
ClinicalTrials.gov
Patient Preference Comparison of AZARGA Versus COSOPT After Single Doses in Patients With Open-Angled Glaucoma or Ocular Hypertension
INTERVENTIONAL
Inicio: 1 de sept de 2010
ID: NCT01471158
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel Group, Multicenter Study of Fluticasone Furoate/Vilanterol 200/25 mcg Inhalation Powder, Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, and Fluticasone Furoate 100 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents
INTERVENTIONAL
Inicio: 20 de sept de 2012
ID: NCT01686633
Completado
Fase 4
ClinicalTrials.gov
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation.
INTERVENTIONAL
Inicio: 1 de jun de 2014
ID: NCT01803438
Terminado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel Group, Adaptive Phase 3 Study With Open-label Extension to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
INTERVENTIONAL
Inicio: 7 de jul de 2020
ID: NCT04271475
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind, Parallel-Group, Multicenter, Non-inferiority Study Comparing the Efficacy and Safety of Rivaroxaban (BAY 59-7939) With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00403767
Completado
ClinicalTrials.gov
SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
OBSERVATIONAL
Inicio: 7 de mar de 2018
ID: NCT03452293
Reclutando
Fase 3
ClinicalTrials.gov
Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
INTERVENTIONAL
Inicio: 8 de may de 2023
ID: NCT05636176
Completado
Fase 1
ClinicalTrials.gov
A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries
INTERVENTIONAL
Inicio: 1 de sept de 2006
ID: NCT00349908
Desconocido
ClinicalTrials.gov
WHF COVID-19 and Cardiovascular Disease Survey
OBSERVATIONAL
Inicio: 1 de sept de 2020
ID: NCT04475471
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Double-dummy, Parallel Group, Multicenter Study of Once Daily Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, Twice Daily Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Twice Daily Fluticasone Propionate 250 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents Already Adequately Controlled on Twice-daily Inhaled Corticosteroid and Long-acting beta2 Agonist
INTERVENTIONAL
Inicio: 1 de mar de 2015
ID: NCT02301975
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Randomized Study of Nilotinib vs. Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Patients With Evidence of Persistent Leukemia by RQ-PCR.
INTERVENTIONAL
Inicio: 1 de jun de 2009
ID: NCT00760877
Anterior
1
...
15
16
17
...
434
Siguiente
Filtros